Research Priorities

  • Substances
    • Cannabis, including:
      • Commonly used forms of marijuana: flower, resin, extracts, purified cannabinoids, and cannabidiol
      • Routes of administration
      • Consequences
      • Impacts of changing laws and policies
      • Potential therapeutic benefits or harms
    • New Psychoactive Substances (NPS), particularly:
      • Synthetic opioids including fentanyl and its analogues
      • Other NPS entering wide use
    • Opioids
      • Prescription opioids
      • Heroin
      • Injection and non-injection use
    • Psychostimulants
      • Cocaine
      • Methamphetamine
      • Other amphetamine-type stimulants
    • Inhalants
    • Tobacco and nicotine, including
      • E-cigarettes
      • Vaping
  • Topics
    • Basic research on neuroscience and biology
    • Epidemiology, intervention, and implementation research
    • Recovery research
    • Policy research
    • Linkages between HIV/AIDS and drug use